Myriad Genetics (MYGN) FCF Margin Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn | 221.00 |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn | -921.00 |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn | 819.00 |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn | -891.00 |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn | 175.00 |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 3,681.00 |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn | 896.00 |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn | 327.00 |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn | 54.00 |
| 10 | Myriad Genetics | 294.69 Mn | 170.29 Mn | 137.60 Mn | 2,076.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,076.00 |
| Dec 31, 2025 | 1,513.00 |
| Sep 30, 2025 | 1,773.00 |
| Jun 30, 2025 | 2,789.00 |
| Mar 31, 2025 | 2,099.00 |
| Dec 31, 2024 | 945.00 |
| Sep 30, 2024 | 2,929.00 |
| Mar 31, 2024 | -4,648.00 |
| Dec 31, 2023 | 306.00 |
| Sep 30, 2023 | 8.00 |
| Jun 30, 2023 | -382.00 |
| Mar 31, 2023 | -3,971.00 |
| Dec 31, 2022 | -2,400.00 |
| Sep 30, 2022 | -2,159.00 |
| Jun 30, 2022 | -4,942.00 |
| Mar 31, 2022 | -3,364.00 |
| Dec 31, 2021 | -2,417.00 |
| Sep 30, 2021 | -3,382.00 |
| Mar 31, 2021 | 3,268.00 |
| Dec 31, 2020 | -4,366.00 |